Copyright information:Taken from "Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience"http://www.issoonline.com/content/4/1/24International seminars in surgical oncology : ISSO 2007;4():24-24.Published online 16 Oct 2007PMCID:PMC2117002.1–769 days; T3/non-NAC: median survival: 554 days, 95% CI = 356–752 days; T3/NAC: median survival: 870 days, 95% CI = 407–1333 days; p = 0.65).